Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.
Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.
Neuropharmacology. 2018 May 15;134(Pt B):240-248. doi: 10.1016/j.neuropharm.2017.09.033. Epub 2017 Sep 22.
Intracerebral hemorrhage (ICH) is the most common hemorrhagic stroke subtype, and rates are increasing with an aging population. Despite an increase in research and trials of therapies for ICH, mortality remains high and no interventional therapy has been demonstrated to improve outcomes. We review known mechanisms of injury, recent clinical trial results, and newly discovered signaling pathways involved in hematoma clearance. Enthusiasm remains high for methods of minimally invasive clot removal as well as pharmacologic strategies to improve recovery after ICH, both of which are currently being evaluated in clinical trials. This article is part of the Special Issue entitled 'Cerebral Ischemia'.
脑出血(ICH)是最常见的出血性中风类型,随着人口老龄化,其发病率正在上升。尽管对 ICH 的治疗方法进行了更多的研究和试验,但死亡率仍然很高,没有介入治疗被证明可以改善预后。我们回顾了已知的损伤机制、最近的临床试验结果以及新发现的与血肿清除相关的信号通路。目前正在临床试验中评估微创清除血栓的方法和改善 ICH 后恢复的药物策略,人们对这两种方法的兴趣仍然很高。本文是特刊“脑缺血”的一部分。